Macrophages in myocardial hypertrophy, fibrosis and failure.

10 July 2016 (08:50 - 09:10)

Organised by:

About the speaker

Doctor Anna Papageorgiou

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail

Macrophage migration inhibitory factor: dual cardioprotective and exacerbating role in ischemic cardiac disease

Professor J. Bernhagen (Munich, DE)

Presentation thumbnail

Epigenetic regulation of macrophages

Professor M. De Winther (Amsterdam, NL)

Presentation thumbnail

Effects of DPP4 inhibition on cardiac regeneration and macrophage balance in a mouse model of HHT-1

Ms C. Dingenouts (Leiden, NL)

Abstract Slides

Presentation thumbnail

Myeloid cell regulation by CD200 signalling in atherosclerosis

Miss C. Kassiteridi (Oxford, GB)

Access the full session

Session thumbnail

Macrophages: new frontier in cardiovascular medicine

The Event

Frontiers in CardioVascular Biology 2016

10 July 2016 08:50 CET

You may be interested in

Congress Presentation

Macrophage transcriptome changes in response to cardiac injuries are determined by the type of lesion rather than their ontogenetic nature.

13 April 2024

Congress Session

The strength of scientific integration

19 May 2025

Congress Presentation

Association of the exerkines apelin and irisin with myocardial fibrosis and cardiac dysfunction in early stages of hypertensive heart failure

22 May 2023

Congress Presentation

Reg3 dependent accumulation of macrophages in aging related atrial fibrillation

25 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources